Scientists from Regeneron selected the two most potent, non-competing virus-neutralising antibodies and scaled up production to create the REGN-COV2 cocktail. REGN-COV2's two antibodies bind ...

Regeneron has said it has begun clinical trials of its antibody cocktail therapy for COVID-19, as pharma companies continue their search for treatments as the pandemic continues to cause havoc ...

Why is his proclamation of Regeneron's unproven and experimental antibody cocktail so dangerous? What is commission bias? With some updates about hydroxychloroquine and vitamin D!!

Regeneron has leveraged its monoclonal antibody ... yet a windfall from sales of its covid antibody cocktail as well as continuing solid sales of Eylea and Dupixent still gave the firm more ...

Beyond Libtayo, Regeneron's oncology pipeline includes several promising programs that could add significant revenue the coming years. Fianlimab is the company’s LAG3 antibody, which has ...